Rege Nephro Co.,Ltd
- Biotech or pharma, therapeutic R&D
Rege Nephro is a clinical-stage biotech company developing small molecule for ADPKD discovered through iPSC-derived human disease models and cell therapy for chronic kidney disease by iPSC-derived nephron progenitor cells
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}